Cargando…
Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study
BACKGROUND: Clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 (PD-1) remain unknown. OBJECTIVE: To better characterize the occurrence of vitiligo in patients receiving anti–PD-1. METHODS: The present single-center ambispective cohort study included patients...
Autores principales: | Dousset, Léa, Pacaud, Alize, Barnetche, Thomas, Kostine, Marie, Dutriaux, Caroline, Pham-Ledard, Anne, Beylot-Barry, Marie, Gérard, Emilie, Prey, Sorilla, Andreu, Nicolas, Boniface, Katia, Seneschal, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529074/ https://www.ncbi.nlm.nih.gov/pubmed/34712997 http://dx.doi.org/10.1016/j.jdin.2021.09.002 |
Ejemplares similares
-
Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective Study
por: Valentin, Julie, et al.
Publicado: (2021) -
Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study
por: Ladouceur, Alexandra, et al.
Publicado: (2023) -
Long-lasting cutaneous tuberculosis owing to Mycobacterium bovis masquerading as sarcoidosis
por: Dequidt, Laure, et al.
Publicado: (2018) -
Vitiligo, From Physiopathology to Emerging Treatments: A Review
por: Migayron, Laure, et al.
Publicado: (2020) -
Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy
por: Dupuis, Frantz, et al.
Publicado: (2018)